Recombinant Wiskott Aldrich Syndrome Protein (WASP)

WAS; IMD2; THC; Eczema-Thrombocytopenia

  • Recombinant Wiskott Aldrich Syndrome Protein (WASP) Packages (Simulation)
  • Recombinant Wiskott Aldrich Syndrome Protein (WASP) Packages (Simulation)
  • RPB917Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Wiskott Aldrich Syndrome Protein (WASP)

USAGE of the Recombinant Wiskott Aldrich Syndrome Protein (WASP)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Wiskott Aldrich Syndrome Protein (WASP)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Wiskott Aldrich Syndrome Protein (WASP)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPB917Hu01 Recombinant Wiskott Aldrich Syndrome Protein (WASP) Positive Control; Immunogen; SDS-PAGE; WB.
PAB917Hu01 Polyclonal Antibody to Wiskott Aldrich Syndrome Protein (WASP) WB,IHC
GUESTBOOK